A new company formed offering full-scale facilities to develop cell and gene therapy products spun-off from academic research labs. . . . → Read More: Company Helps Labs Build Gene, Cell Therapy Businesses
|
|||||
|
|
So far this year, machine learning applications and platforms are gaining the most investment dollars worldwide for A.I., this weekend’s infographic. . . . → Read More: Infographic – Machine Learning Grabs Most A.I. Investments 
A collaboration between biopharmaceutical maker Gilead Sciences and biotechnology company Goldfinch Bio aims to develop precision medicines for treating various kidney diseases. . . . → Read More: Companies Partner on Kidney Disease in $2B Deal 
A new biotechnology enterprise plans to apply genetic analysis and the gene-editing technology Crispr to reduce the risk of coronary artery disease. . . . → Read More: Start-Up to Use Crispr for Heart Disease, Gains $59M 
Researchers developed a synthetic soft tissue for plastic and reconstructive surgery that in animal tests looks and performs more like real tissue. . . . → Read More: Synthetic Soft Tissue Developed for Surgery  Comments are closed  New products  biomedical, biotechnology, engineering, entrepreneurs, equity, investment, licensing, life sciences, materials science, medical device, pharmaceuticals, physical sciences, preclinical, university, venture capital 
Venture capital investments worldwide declined in the first quarter of 2019, compared to the near record-setting pace of the last 3 months of 2018. . . . → Read More: Infographic – Venture Deals Cool Off in Q1 2019 One comment - (Comments are closed) Finance entrepreneurs, equity, investment, mathematics, venture capital 
Two biotechnology companies plan to develop new therapies mainly for eye and neurological diseases that silence genes responsible for those conditions. . . . → Read More: Biotechs Partner on Gene Silencing in $1.1B Deal Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, equity, genomics, investment, licensing, life sciences, pharmaceuticals 
A company creating cancer treatments that combine radiation therapy with the targeting of synthetic antibodies is raising $105 million in its second round of venture financing. . . . → Read More: Radiation-Antibody Biotech Raises $105M in Venture Funds Comments are closed Finance biomedical, biotechnology, Canada, cancer, clinical trials, entrepreneurs, equity, investment, life sciences, pharmaceuticals, university, venture capital 
A biotechnology company developing treatments for disease and enhanced agricultural products with genome editing is raising $126 million in its initial public offering, or IPO, of common stock. . . . → Read More: Genome Editing Biotech Raises $126M in IPO Comments are closed Finance agriculture, biomedical, biotechnology, cancer, equity, genomics, investment, IPO, life sciences, pharmaceuticals 
A company developing vaccines that protect against respiratory diseases in vulnerable populations is raising new seed funds to advance its lead product into clinical trials. . . . → Read More: Respiratory Vaccine Maker Raises $3.4M in Seed Funds Comments are closed Finance, New products biomedical, biotechnology, clinical trials, entrepreneurs, equity, grant, investment, life sciences, NIH, pharmaceuticals, preclinical, university, venture capital |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||